A detailed history of Black Rock Inc. transactions in Voyager Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 5,312,617 shares of VYGR stock, worth $30.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,312,617
Previous 4,397,444 20.81%
Holding current value
$30.4 Million
Previous $40.9 Million 2.64%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$7.42 - $10.54 $6.79 Million - $9.65 Million
915,173 Added 20.81%
5,312,617 $42 Million
Q1 2024

May 10, 2024

BUY
$7.15 - $10.84 $12.6 Million - $19.1 Million
1,764,765 Added 67.03%
4,397,444 $40.9 Million
Q4 2023

Feb 13, 2024

BUY
$6.28 - $8.81 $1.05 Million - $1.47 Million
167,291 Added 6.79%
2,632,679 $22.2 Million
Q3 2023

Nov 13, 2023

SELL
$7.55 - $11.25 $90,690 - $135,135
-12,012 Reduced 0.48%
2,465,388 $19.1 Million
Q2 2023

Aug 11, 2023

BUY
$6.94 - $13.99 $11.5 Million - $23.1 Million
1,653,613 Added 200.73%
2,477,400 $28.4 Million
Q1 2023

May 12, 2023

SELL
$6.0 - $10.78 $114,822 - $206,296
-19,137 Reduced 2.27%
823,787 $6.35 Million
Q4 2022

Feb 13, 2023

BUY
$4.94 - $6.61 $1.25 Million - $1.67 Million
252,420 Added 42.75%
842,924 $5.14 Million
Q3 2022

Nov 14, 2022

BUY
$5.57 - $7.47 $146,429 - $196,378
26,289 Added 4.66%
590,504 $3.5 Million
Q2 2022

Aug 12, 2022

BUY
$4.82 - $10.09 $241,289 - $505,105
50,060 Added 9.74%
564,215 $3.33 Million
Q1 2022

May 12, 2022

BUY
$2.75 - $9.44 $135,627 - $465,571
49,319 Added 10.61%
514,155 $3.92 Million
Q4 2021

Feb 10, 2022

SELL
$2.47 - $5.55 $1.15 Million - $2.59 Million
-465,899 Reduced 50.06%
464,836 $1.26 Million
Q3 2021

Nov 09, 2021

SELL
$2.63 - $4.12 $31,378 - $49,155
-11,931 Reduced 1.27%
930,735 $2.45 Million
Q2 2021

Aug 11, 2021

BUY
$3.94 - $5.44 $3.71 Million - $5.13 Million
942,666 New
942,666 $3.89 Million

Others Institutions Holding VYGR

About Voyager Therapeutics, Inc.


  • Ticker VYGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,647,600
  • Market Cap $221M
  • Description
  • Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...
More about VYGR
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.